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Sera from patients with the acute (AF) and chronic (CF) forms of paracoccidioidomycosis (PCM) were tested
against Paracoccidioides brasiiensis cell-free antigens by Western blot (immunoblot). The CFA preparation
contained components ranging in molecular mass from 18 to 102 kDa. The immunoglobulin G (IgG) reactivity
profiles were similar for patients with both forms of the disease, and the 43-kDa component was recognized by
100% of the sera. IgM antibodies from the AF- and the CF-PCM sera recognized 21 and 20 components,
respectively, the AF-PCM sera reacting preferentially with components with molecular masses above 50 kDa.
None of the AF-PCM sera (IgM) reacted with the 43-kDa component, and only 10%Yl of the CF-PCM sera
recognized this molecule. The IgA response was more significant in the CF-PCM group than in the AF-PCM
group, and the 43- and 74-kDa components were the most reactive ones (about 40%o each). Our results showed
that the cell-re antigen preparation is very appropriate for the immunoblotting analysis of PCM sera, and
they also showed that the detection of IgG anti-gp43 is the best marker for the diagnosis and the following up
of patients with the acute or the chronic form of the disease.
The systemic mycosis paracoccidioidomycosis (PCM) is
caused by the dimorphic fungus Paracoccidioides brasilien-
sis, and it presents a wide spectrum of clinical manifesta-
tions. Over the years, it has been suggested that infection
with P. brasiliensis occurs by inhalation of the airborne
mycelial structures (not yet defined) of the saprobic phase of
the fungus. Once in the lungs, the propagules convert
themselves into the yeast phase, initiating the infection, and
then they eventually disseminate themselves to the other
parts of the body (9). Two main clinical forms of the disease
are recognized by the International Committee of PCM (10),
namely, the acute or subacute form (AF) and the unifocal or
multifocal chronic form (CF). The pathogen is endemic to
many regions of Latin America, mainly in Argentina, Brazil,
Colombia, and Venezuela.
The diagnosis of PCM can be made by direct observation
of the characteristic multiple-budding cells in clinical mate-
rials, by biopsy, or by culture. However, when these proce-
dures are not available, the detection of antibodies to P.
brasiliensis antigens is a valuable aid for diagnosing PCM,
mainly by the immunodiffusion test (6).
In general, the antigenic preparations used in serological
assays for P. brasiliensis antibodies have been undefined,
and it is unknown if there is any relationship between the
various antigens and the clinical forms of PCM. We have
recently described a simple method for obtaining antigen
from the surface of the fungus, which was designated "cell-
free antigen" (CFA) (5).
In this study, the Western blot (immunoblot) assay was
used to analyze the main components of P. brasiliensis CFA
recognized by the individual immunoglobulin G (IgG), IgM,
and IgA in sera from patients with the acute and the chronic
forms of PCM, because of the fact that the CFA preparation
is composed by the cell surface-associated antigens which
might represent the first molecules to have contact with the
host defense cells.
MATERIALS AND METHODS
Fungal strain. P. brasiliensis B-339 (kindly provided by A.
Restrepo, Corporacion para Investigaciones Biologicas,
Medellin, Colombia) was maintained by frequent subcultur-
ing on Sabouraud glucose agar (Difco Laboratories). The





FIG. 1. Components of the CFA of P. brasiliensis after SDS-
PAGE and silver staining. Molecular mass standards are indicated at
the right.* Corresponding author.
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FIG. 2. IgG, IgM, and IgA immunoblots of the CFA of P. brasiliensis B-339, revealed with 30 PCM-AF and 30 PCM-CF serum samples.
such medium at 35°C and was maintained in such form by
being subcultured every third day.
Preparation of antigen. P. brasiliensis B-339 was grown on
Sabouraud glucose agar at 35°C for 3 days. The fungal
growth from three randomly selected tubes (about 300 mg,
wet weight) was collected by gently scraping the surface.
The cell mass was suspended in 1 ml of 0.15 M phosphate-
buffered saline (PBS), pH 7.4, mixed for 30 s in a Vortex
mixer (Tecnal, Sao Paulo, Brazil), and immediately centri-
fuged at 10,000 x g in an Eppendorf tabletop centrifuge
(Sorvall MC 12V; Dupont, Newtown, Conn.) for 60 s. The
resulting supernatant fluid contained the antigen (CFA). The
protein concentration in CFA was determined by the method
of Bradford (4).
Sera. Serum samples were obtained from 60 PCM patients
from the Hospital das Clinicas da UNICAMP, Campinas,
Brazil. The patients were all Caucasians, grouped according
to the clinical form of the disease as follows: 30 patients (30
serum samples) were 6 to 32 years of age with the acute form
(PCM-AF), and 30 patients (30 serum samples) were 35 to 69
years of age with the chronic form (PCM-CF). Most of them
were rural workers from the region of Campinas. These sera
were taken before antimycotic therapy. Ten patients in each
group were serologically monitored for 2 years during the
course of therapy (adding up to 50 serum samples).
SDS-PAGE. CFA obtained as described above was mixed
with the reducing sample buffer containing 62.5 mM Tris-
HCl, pH 6.8, 2% sodium dodecyl sulfate (SDS), 10% glyc-
erol, 10% 2-mercaptoethanol, and 0.05% bromophenol blue.
The polypeptides were separated by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) (11) on 10% acrylamide
gels. Protein standards with the following molecular masses
were used: bovine serum albumin, 67,000 Da; ovalbumin,
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FIG. 3. Histograms of the frequencies of binding of IgG, IgM, and IgA from 30 PCM-AF and 30 PCM-CF serum samples to the
components of the CFA of P. brasiliensis B-339.
Uppsala, Sweden). Proteins were visualized by silver nitrate
staining (1).
Immunoblotting. After electrophoresis, the CFA proteins
were transferred overnight to nitrocellulose paper (NCP) at
100 mA in a transblotting chamber (Bio-Rad, Melville, N.Y.)
(15, 16). The transfer buffer consisted of 25 mM Tris, 192
mM glycine, and 20% (vol/vol) methanol, pH 8.3. Prior to
the immunological staining, the free sites on the NCP were
blocked with 2% bovine serum albumin (BSA; Sigma) in
PBS and 0.2% Nonidet P-40 (Sigma), pH 7.4, for 4 h. The
NCP was sliced vertically, and the strips were incubated
individually for 60 min at room temperature with sera from
patients with PCM diluted at 1:100 in PBS containing 0.02%
Tween 20 and 0.25% gelatin (PBS-T-G). Then, each strip
was washed four times for 15 min in PBS-T-G and afterwards
incubated individually with peroxidase anti-human IgG, IgA,
or IgM (Sigma) for 60 min. Afterwards, each strip was
washed four times for 15 min in PBS-T-G and incubated with
a freshly prepared mixture of 5 mg of DAB (3,3-diaminoben-
zidine-4HCl; Sigma) in 50 ml of 0.1 M Tris buffer, pH 7.5,
plus 5 pl of 30% H202. After color development, the strips
were rinsed in 10% acetic acid.
Scanning densitometry. After immunoblotting, each NCP
strip incubated with the sera obtained from patients moni-
tored during antimycotic therapy was analyzed by scanning
densitometry (CS 9000; Shimadzu Corporation Spectropho-
tometric Instrument Plant, Kyoto, Japan) at 550 nm for
quantitative evaluation of the band intensity.
RESULTS
The components of the CFA of P. brasiliensis B-339 were
analyzed by SDS-PAGE. At least 42 components (18 to 102
kDa) were observed after silver staining (Fig. 1).
Fig. 2 shows IgG, IgM, and IgA blots of CFA components
exposed to 30 individual AF-PCM serum samples and to 30
individual CF-PCM serum samples (all obtained before
therapy). Several components of the following molecular
masses were detected in IgG-positive patient serum samples:
18, 20, 22, 24, 28, 29, 33, 34, 39, 43, 50, 52, 54, 58, 60, 62, 64,
66, 68, 70, 72, 74, 76, 78, 80, 82, 86, 88, 90, 96, and 102 kDa.
The number of components varied with the PCM serum. The
AF-PCM sera (IgG) recognized 30 components, whereas the
CF-PCM sera recognized 23 components. Patients with both
forms of the disease had similar IgG reactivity profiles. The
most frequent components that reacted with the IgG-AF
serum group were 24 and 28 kDa (20%), 20, 22, and 78 kDa
(25%), 76 kDa (28%), 80 kDa (30%), 70 kDa (45%), and 43
kDa (100%), whereas for the IgG-CF serum group, the
components that reacted most frequently were 28 kDa
(20%), 22 and 88 kDa (25%), 70 kDa (35%), and 43 kDa
(100%).
IgM blots of the CFA exposed to 30 individual AF-PCM
serum samples and to 30 individual CF-PCM serum samples
recognized 21 and 19 components, respectively. Note that
the components with molecular masses of 22, 24, 28, 29, 34,
35, 36, 39, 43, 47, 50, 52, 54, 58, 60, 62, 64, 66, 70, 72, 74, 76,
80, 82, 86, 88, and 90 kDa were recognized, but the number
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FIG. 4. Immunoblots (C) and corresponding densitometries of
the IgG responses of AF-PCM sera (patient 8) before (A) and after
(B) 1 year of antimycotic therapy.
with AF-PCM reacted preferentially with components with
molecular masses above 50 kDa. The most frequent reactive
components for IgM-AF serum group were 50, 58, and 66
kDa (20%); 64, 82, and 88 kDa (40%); 90 kDa (55%); 80 kDa
(60%); and 70 kDa (70%), whereas those for the IgM-CF
group were 70 and 80 kDa (20%) and 88 and 90 kDa (30%).
IgA blots of CFA exposed to the same serum groups
recognized 10 and 26 components, respectively. Various
antigens with molecular masses of 20, 22, 24, 26, 28, 30, 32,
36, 38, 43, 46, 48, 50, 54, 56, 58, 60, 62, 64, 66, 70, 72, 74, 76,
80, and 82 kDa were detected. The number of antigens also
varied with the individual PCM serum used. IgA antibodies
were absent in 73% of the sera from patients with the
AiF-PCM, whereas the CF-PCM sera were able to recognize
a more extensive set of antigens. The most frequent reactive
components for the IgA-AF serum group were 24, 43, 70,
and 76 kDa (10%), whereas those for the IgA-CF group were
46, 60, and 80 kDa (25%), 24 kDa (30%), and 43 and 74 kDa
(40%).
Figure 3 presents the individual frequencies of recognition
of CFA components by IgG, IgM, and IgA of AF-PCM and
.4# gewA: B :.'....
FIG. 5. Immunoblots (C) and corresponding densitometries of
the IgG responses of CF-PCM sera (patient 9) before (A) and after
(B) 1 year of antimycotic therapy.
CF-PCM sera. The 43-kDa component was recognized by
IgG in 100% of both groups of sera, followed by the 70-kDa
component, which was recognized by 50% of the IgG sera.
On the other hand, none of the IgM AF-PCM sera reacted
with the 43-kDa component.
Profiles of immunoblots (IgG antibodies) obtained with
sera from patients 8 (AF-PCM) and 9 (CF-PCM) undergoing
treatment are shown in Fig. 4 and 5, respectively. The
corresponding densitometries of IgG blots showed a de-
crease in antibodies against the gp43 molecule. Before
therapy, patient 8 (AF) registered 18,408 mm2 (IgG anti-
gp43), whereas 1 year later, patient 8's corresponding read-
ing decreased to 11,851 mm2; enzyme-linked immunosorbent
assay (ELISA) anti-gp43 titers were 1:102,000 and 1:12,800,
respectively (data not shown), in agreement with the densi-
tometric analysis. Patient 9 (CF) had antibody densitome-
tries of 8,428 mm2 before treatment and 5,108 mm2 after 1
year of therapy and ELISA titers of 1:51,600 and 1:6,400,
respectively (data not shown). Similar results were obtained
with the other patients (data not shown), indicating that the
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DISCUSSION
Identification of antigens eliciting an antibody response to
an infectious agent can lead to understanding of the immune
response to a pathogenic organism at the level of individual
molecules or epitopes. Such knowledge is the basis of
current strategies for the development of simplified subunit
vaccines to give protection against diseases (2). The P.
brasiliensis CFA is composed of various molecules loosely
bound to the yeast cell surface which are easily detached by
being suspended in an aqueous solution. These molecules
are probably more protected against endogenous proteases
than those excreted into liquid culture medium, in which
there are proteases released from dead cells during cell
growth. These presumably better-preserved CFA molecules
may mimic the antigens released in vivo from the cells in the
site of the infection or released into the circulation, where
they become available for interaction with the cells of the
immune system.
Various investigators have used the immunoblot approach
to study the humoral response to PCM. However, the
antigenic preparations used for this purpose were exoanti-
gens from aged filtrate cultures (7, 8, 12). The CFA, a young
growth preparation, is constituted of 42 components ranging
from 18 to 102 kDa, the 43-kDa component being the major
glycoprotein excreted by the fungus (5).
Our results indicate that despite the clinical form of the
disease, the IgG antibodies were able to recognize quite
similar components of the CFA. In both forms, the 43- and
the 70-kDa major components were recognized by 100 and
50% of the sera studied, respectively. Molecules 70, 74, 76,
78, and 80 kDa in size were more reactive in the acute form
than in the chronic form.
Vaz et al. (17) showed with a murine experimental PCM
that a diffuse 43- to 47-kDa band was recognized by all sera
tested, and the IgG against it was present at a high frequency
during the whole period of infection. In a previous study,
Camargo et al. (7) found 100% reactivity of IgG anti-gp43 in
PCM sera. Casotto et al. (8) showed that the IgG sera from
92% of the PCM patients recognized the 43-kDa component
from P. brasiliensis B-339.
We found that IgM response to the CFA antigens was
more intense against components with molecular masses
greater than 50 kDa, mainly 54, 58, 60, 70, 80, 82, 86, 88, and
90 kDa, in the acute form of PCM than in the chronic form.
No response against the 43-kDa component in the AF-PCM
sera was verified, and fewer than 10% of the CF-PCM sera
recognized the 43-kDa component. On the other hand,
Mendes-Giannini et al. (12) found 100% reactivity with IgM
anti-gp43 in both clinical forms of the disease. Vaz et al. (17)
in their murine experimental PCM study found great reac-
tivity of IgM against the diffuse 43- to 47-kDa band during
the period of infection (16 weeks). The differences between
our results and those obtained by others may be due to
differences in the glycosylation process of the gp43 mole-
cule, which seems to be dependent on the strain and on the
substrate on which the fungi were cultured. In this way,
carbohydrate epitopes might be inaccessible to IgM antibod-
ies in this kind of P. brasiliensis CFA preparation.
The IgA response was significant in the CF-PCM group,
and was directed mainly against the components with mo-
lecular masses of 20, 24, 26, 43, 46, 50, 58, 60, 70, 76, and 80
kDa, whereas a poor IgA response was obtained in the
AF-PCM group. The 43- and 74-kDa components were the
most reactive components in chronic PCM (about 40%
reactivity each).
Our study showed that the CFA preparation is very useful
in immunoblot analysis of humoral responses in PCM.
Regarding the Ig class, the IgG response has apparently been
the best one to be studied once it recognizes quite similar
antigenic components in both clinical forms of the disease.
Regarding the antigenic component to be selected for anal-
ysis of serum reactivity, the 43-kDa glycoprotein seems to
represent the most important antigenic component of the
PCM system.
Antigenic variability in the murine PCM model and even in
the human PCM, with respect to the specific molecules
involved in the P. brasiliensis system, was observed (8, 17).
Casotto et al. (8) showed that this variability may be ob-
served not only among different isolates ofP. brasiliensis but
also among antigens with the same molecular mass. In their
study, the 44-kDa molecule (probably similar to our gp43) of
three different strains of P. brasiliensis was recognized by
the same serum only in two strains (B339 and 688) and not in
strain 1789.88. Vaz et al. (17), working with resistant and
susceptible mice, found significant differences in the IgM
responses to many components. The susceptible mice rec-
ognized fewer components than the resistant mice. These
findings may explain the different results obtained by various
researchers.
For serological studies, we suggest the use of the P.
brasiliensis B-339 isolate, which has been investigated by
various groups during the last 20 years (3, 6, 13) and which
contains specific antigen recognized by 96% (14) to 100% (7,
12) of the PCM sera. Casotto et al. (8) verified that freshly
isolated virulent strain 1789.88 did not appear to be useful for
diagnostic purposes, whereas isolates B339 and 688, which
had been subcultured for many years, appear to be better.
On the basis of the present findings, as well as previous
reports, and because the gp43 component is recognized by
all or almost all of the PCM sera (IgG), we propose that
measurement or titration of IgG anti-gp43 be used for the
following up of patients under antimycotic therapy. This
may be done by the reading of IgG blots by densitometry or
by titration of sera by ELISA.
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